Original Research

Anti-CD22 CAR-T Cell Therapy as a Salvage Treatment in B Cell Malignancies Refractory or Relapsed After Anti-CD19 CAR-T therapy

Zhu H, Deng H, Mu J, Lyu C, Jiang Y, Deng Q

OncoTargets and Therapy 2021, 14:4023-4037

Published Date: 2 July 2021